Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH agonist with or without letrozole before FET in infertile women with endometriosis
IRCT20241107063631N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of triptorelin, letrozole and estradiol in endometriosis and female infertility (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Positive pregnancy test, Abortion rate and 2 more. Started Nov 2024; status: completed.
02
Drugs
triptorelinletrozoleestradiol
03
Conditions
endometriosisfemale infertility
Beyond the preview
Go deeper on IRCT20241107063631N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241107063631N2.